The Life Raft Group was recently part of team of authors on a collaborative position paper entitled 'Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours (GISTs) incorrectly classified as wild-type published' in Pathology: The Journal of the Royal College of Pathologists of Australia.
The Life Raft Group partnered with Dr. Michael Wagner of the University of Washington to present “The Importance of Biomarker Testing” to GIST patients and caregivers on August 12th, 2022.
Dr. Jason SIcklick, UC San Diego Moores Cancer Center presented The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy at Life Fest 2022 in New Orleans.
Dr. Gina D'Amato, Sylvester Comprehensive Cancer Center University and Dr. Breelyn WIlky, University of Colorado Cancer Center, presented Management of GIST & Treatment-related Symptoms at Life Fest 2022 in New Orleans.
Dr. Andrew Blakely, National Cancer Institute, NIH, presented GISTs: Surgery Basics at Life Fest 2022 in New Orleans.
Piga Fernández, GIST Mentor & LRG Global Consultant, presented a Survival Plan for patients and caregivers at Life Fest New Orleans 2022.
Dr. Aimee Crago, Memorial Sloan Kettering, presented Management of Metastatic GIST at Life Fest 2022 in New Orleans.
At Life Fest New Orleans, current Board President Gary Glasser gave a tribute to past president Jerry Cudzil, longtime board president, and avid GIST advocate.
Dr. mOe Anderson, Mistress of Ceremonies, Life Fest 2022, shares her GISTory.
Patient advocate Josalin Dunn honored retired Executive Director Norman Scherzer for his decades of work on behalf of the GIST community.
